ArticleEJHaem2022

Humoral and cellular immune response in patients with hematological disorders after two doses of BNT162b2 mRNA COVID-19 vaccine: A single-center prospective observational study (NCT05074706).

Elisa Bossi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.